VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACICAmerican Coastal Insurance Corporation
$11.52$558M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACICQuarterly Financials

American Coastal Insurance Corporation (ACIC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

American Coastal Insurance Corporation (ACIC) quarterly income statement — complete revenue, gross profit & net income history

ACIC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue71.22M86.38M90.29M86.36M72.08M79.05M82.14M68.69M66.52M58.21M52.53M73.54M90.32M113.47M72.75M63.91M58.43M154.54M162.74M155.45M
Revenue Growth %-1.19%9.27%9.93%25.72%8.37%35.79%56.35%-6.59%-26.35%-48.7%-27.79%15.07%54.57%-26.57%-55.3%-58.89%-63.88%-35.93%-23.5%-28.16%
Medical Costs & Claims10.24M9.9M35.98M40.17M35.23M56.31M32.72M29.69M23.64M27M23.43M39.77M43.38M401.12M78.8M37.6M46.62M130.02M149.69M159.39M
Medical Cost Ratio %14.38%11.46%39.85%46.51%48.87%71.23%39.83%43.22%35.54%46.38%44.6%54.08%48.03%353.49%108.31%58.84%79.79%84.13%91.98%102.53%
Gross Profit60.98M76.47M54.31M46.19M36.85M22.74M49.42M39.01M42.88M31.21M29.1M33.77M46.94M-287.64M-6.04M26.31M11.81M24.52M13.05M-3.94M
Gross Margin %85.62%88.54%60.15%53.49%51.13%28.77%60.17%56.78%64.46%53.62%55.4%45.92%51.97%-253.49%-8.31%41.16%20.21%15.87%8.02%-2.53%
Gross Profit Growth %65.46%236.32%9.89%18.42%-14.04%-27.15%69.8%15.5%-8.65%110.85%581.62%28.37%297.46%-1272.95%-146.32%768.22%127.67%352.01%120.18%-106.34%
Operating Expenses35.23M39.86M11.94M8.64M10.66M13.85M12.9M14.12M11.51M11.63M11.05M11.37M13.09M8.83M21.47M14.13M12.8M30.73M31.65M28.84M
OpEx / Revenue %49.46%46.14%13.22%10%14.79%17.52%15.71%20.55%17.3%19.98%21.03%15.46%14.5%7.78%29.51%22.11%21.9%19.88%19.45%18.55%
Depreciation & Amortization861K6.6M1.63M1.69M1.72M2.25M2.5M1.95M2.17M4.24M2.11M2.13M2.15M2.24M16.03M2.44M2.61M2.72M2.79M3.05M
Combined Ratio %63.84%57.61%53.07%56.52%63.66%88.76%55.54%63.77%52.84%66.36%65.63%69.54%62.53%361.27%137.82%80.95%101.69%104.01%111.43%121.08%
Operating Income25.75M36.62M42.37M37.55M26.19M8.89M36.52M24.89M31.37M19.59M18.06M22.4M33.84M-296.47M-27.51M12.18M-988K-6.2M-18.6M-32.77M
Operating Margin %36.16%42.39%46.93%43.48%36.34%11.24%44.46%36.23%47.16%33.64%34.37%30.46%37.47%-261.27%-37.82%19.05%-1.69%-4.01%-11.43%-21.08%
Operating Income Growth %-1.68%312.04%16.03%50.89%-16.49%-54.63%102.23%11.11%-7.32%106.61%165.63%83.97%3525.51%-4680.26%-47.91%137.15%96.24%86.29%81.5%-211.16%
EBITDA26.61M43.22M44M39.24M27.92M11.14M39.02M26.83M33.54M23.82M20.17M24.52M36M-294.23M-11.48M14.61M1.62M-3.48M-15.81M-29.73M
EBITDA Margin %37.37%50.04%48.73%45.44%38.73%14.1%47.5%39.06%50.42%40.92%38.39%33.35%39.86%-259.29%-15.78%22.86%2.77%-2.25%-9.71%-19.12%
Interest Expense2.34M2.66M2.72M2.72M2.72M2.78M3.07M3.43M2.72M2.72M2.72M2.72M2.72M2.45M2.36M2.36M2.36M2.38M2.38M2.26M
Non-Operating Income-2.34M-2.66M-2.72M-2.72M-2.72M-2.78M-3.07M-3.43M-2.72M-2.72M-2.72M-2.72M-2.72M-2.45M-2.36M-2.36M-2.36M-2.38M-2.38M-2.26M
Pretax Income25.75M36.62M42.37M37.55M26.19M8.89M36.52M24.89M31.37M19.59M18.06M22.4M33.84M-296.47M-27.51M12.18M-988K-6.2M-18.6M-32.77M
Pretax Margin %36.16%42.39%46.93%43.48%36.34%11.24%44.46%36.23%47.16%33.64%34.37%30.46%37.47%-261.27%-37.82%19.05%-1.69%-4.01%-11.43%-21.08%
Income Tax6.5M10.05M9.89M9.52M6.48M3.02M8.85M5.81M7.66M2.48M3.04M1.15M3.48M298K-66K25.49M-715K-3.33M-3.48M-9.35M
Effective Tax Rate %25.24%27.46%23.33%25.34%24.75%33.97%24.23%23.36%24.42%12.66%16.85%5.15%10.27%-0.1%0.24%209.33%72.37%53.74%18.72%28.54%
Net Income19.25M26.56M32.48M26.44M21.35M4.95M28.12M19.05M23.6M14.28M10.57M17.78M267.28M-296.77M-70.88M-69.03M-33.17M-2.32M-14.32M-23.51M
Net Margin %27.03%30.75%35.98%30.62%29.62%6.26%34.23%27.74%35.48%24.54%20.12%24.18%295.93%-261.53%-97.43%-108.01%-56.77%-1.5%-8.8%-15.12%
Net Income Growth %-9.81%437.08%15.52%38.77%-9.54%-65.37%166.08%7.17%-91.17%104.81%114.91%125.76%905.74%-12713.9%-394.93%-193.62%-86.66%93.17%80.66%-196.85%
EPS (Diluted)0.390.530.650.530.430.100.570.390.480.310.240.415.99-6.84-1.65-1.60-0.77-0.05-0.33-0.55
EPS Growth %-9.3%430%14.04%35.9%-10.42%-67.74%137.5%-4.88%-91.99%104.53%114.55%125.63%877.92%-12590.17%-400%-190.91%-87.8%93.18%80.92%-198.21%
EPS (Basic)0.400.550.670.550.410.100.590.400.500.320.240.416.05-6.84-1.65-1.61-0.77-0.05-0.33-0.55
Diluted Shares Outstanding49.81M49.93M49.92M49.64M49.56M49.44M49.52M49.4M48.97M45.71M44.14M43.81M43.57M43.1M43.08M43.05M42.98M42.97M42.97M42.95M